Metabolomic biomarkers in serum and urine in women with preeclampsia

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Austdal, Marie ^a,b,c   Skrastad, Ragnhild Bergene ^b,c   Gundersen, Astrid Solberg ^a   Austgulen, Rigmor ^a   Iversen, Ann Charlotte ^a   Bathen, Tone Frost ^a,c  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; METABOLITE; METABOLOMICS; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; PHENOTYPE; PREECLAMPSIA; PREGNANT WOMAN; URINALYSIS; BLOOD; CASE CONTROL STUDY; METABOLOME; NUCLEAR MAGNETIC RESONANCE; PREGNANCY; PROCEDURES; URINE; YOUNG ADULT;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; METABOLOME; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PRE-ECLAMPSIA; PREGNANCY; YOUNG ADULT;

EID: 84898653728     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091923     Document Type: Article

References (28)

1. Bergsjø P, Evensen SR, Steinsholt IM (2001) Preeklampsi og eklampsi. Norsk Elektronisk Legehåndbok.
2. S (Pubitemid 40311367)
3. Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi J-M (2011) Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag 7:467-474.
4. Borzychowski AM, Sargent IL, Redman C W G (2006) Inflammation and preeclampsia. Semin Fetal Neonat M 11:309-316.
5. Redman C W G, Sacks GP, Sargent IL (1999) Preeclampsia: An excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180:499-506. (Pubitemid 29093892)
6. Craici I, Wagner S, Garovic VD (2008) Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test? Ther Adv Cardiovasc Dis 4:249-259.
7. Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, et al. (2011) The human serum metabolome. PloS one 6:e16957.
8. Lindon JC, Nicholson JK, Holmes E, Everett JR (2000) Metabonomics: Metabolic processes studied by NMR spectroscopy of biofluids. Concept Magnetic Res 12:289-320.
9. Turner E, Brewster JA, Simpson N A B, Walker JJ, Fisher J (2007) Plasma from women with preeclampsia has a low lipid and ketone body content - A nuclear magnetic resonance study. Hypertens Pregnancy 26:329-342. (Pubitemid 47295356)
10. Turner E, Brewster JA, Simpson N A B, Walker JJ, Fisher J (2008) Aromatic amino acid biomarkers of preeclampsia - a nuclear magnetic resonance investigation. Hypertens Pregnancy 27:225-235.
11. Schott S, Hahn J, Kurbacher C, Moka D (2012) 31P and 1H Nuclear Magnetic Resonance Spectroscopy of Blood Plasma in Female Patients with Preeclampsia. International Journal of Biomedical Science 8:258.
12. Lorentzen B, Øian P, Staff A, Mortensen J H S (2008) Hypertensive svangerskapskomplikasjoner. Veileder i fødselshjelp 2008: Norsk Gynekologisk forening.
13. Wold S, Sjöström M, Eriksson L (2001) PLS-regression: a basic tool of chemometrics. Chemometrics and Intelligent Laboratory Systems 58:109-130. (Pubitemid 33033283)
14. Savorani F, Tomasi G, Engelsen S (2010) icoshift: a versatile tool for the rapid alignment of 1D NMR spectra. J Magn Res 443:190-202.
15. Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC (1995) 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Analytical chemistry 67:793-811.
16. Dreier L, Wider G (2006) Concentration measurements by PULCON using X-filtered or 2D NMR spectra. Magn Reson Chem 44:206-212.
17. Benjamini Y, Yekutieli D (2001) The control of the false discovery rate in multiple testing under dependency. Annals of Statistics 29:1165-1188. (Pubitemid 33575263)
18. Bathen TF, Krane J, Engan T, Bjerve KS, Axelson D (2000) Quantification of plasma lipids and apolipoproteins by use of proton NMR spectroscopy, multivariate and neural network analysis. NMR Biomed 13:271-288.
19. Diaz SO, Barros AS, Goodfellow BJ, Duarte IF, Carreira IM, et al. (2013) Following healthy pregnancy by nuclear magnetic resonance (NMR) metabolic profiling of human urine. Journal of proteome research 12:969-979.
20. Friesen RW, Novak EM, Hasman D, Innis SM (2007) Relationship of Dimethylglycine, Choline, and Betaine with Oxoproline in Plasma of Pregnant Women and Their Newborn Infants. The Journal of Nutrition 137:2641-2646. (Pubitemid 350255291)
21. Sachse D, Sletner L, Morkrid K, Jenum AK, Birkeland KI, et al. (2012) Metabolic changes in urine during and after pregnancy in a large, multiethnic population-based cohort study of gestational diabetes. PloS one 7:e52399.
22. Braekke K, Ueland PM, Harsem NK, Karlsen A, Blomhoff R, et al. (2007) Homocysteine, Cysteine, and Related Metabolites in Maternal and Fetal Plasma in Preeclampsia. Pediatr Res 62:319-324. (Pubitemid 47301483)
23. Diaz SO, Pinto J, Graca G, Duarte IF, Barros AS, et al. (2011) Metabolic Biomarkers of Prenatal Disorders: An Exploratory NMR Metabonomics Study of Second Trimester Maternal Urine and Blood Plasma. J Proteome Res 10:3732-3742.
24. Watanabe H, Miyamoto Y, Honda D, Tanaka H, Wu Q, et al. (2013) p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int.
25. Bahado-Sing RO, Akolekar R, Mandal R, Dong E, Xia J, et al. (2012) Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern-Fetal Neo M.
26. Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, et al. (2012) Firsttrimester metabolomic detection of late-onset preeclampsia. American journal of obstetrics and gynecology 208:e10-e11.
27. Bolin M, Akerud P, Hansson A, Akerud H (2011) Histidine-rich glycoprotein as an early biomarker of preeclampsia. American journal of hypertension 24:496-501.
28. Demirci O, Tugrul AS, Dolgun N, Sozen H, Eren S (2011) Serum lipids level assessed in early pregnancy and risk of pre-eclampsia. J Obstet Gynaecol Res 37:1427-1432.